Signaling Pathways - Hck - CGRP receptors - GLI - Tie-2
清除全部
- B6012 Pexmetinib (ARRY-614)Target: p38|Tie-2Summary: p38 MAPK 和 Tie2/Tek 受体酪氨酸激酶的双重抑制剂
- B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂
- B4904 ACTB-1003Target: VEGFR|FGFR|Tie-2|RSK|p70 S6KSummary: FGFR1抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
- A1615 GANT611 CitationTarget: GLISummary: GLI拮抗剂
- A5979 Tie2 kinase inhibitor中文名: Tie2激酶抑制剂Target: Tie-2Summary: Tie-2(Tie2 )抑制剂
- A3680 OlcegepantTarget: CGRP receptorsSummary: 降钙素基因相关肽(CGRP)的非肽受体,具有有效性和选择性。
- A3612 MK-0974Target: CGRP receptorsSummary: CGRP受体拮抗剂
- A4124 TAK-901Target: Aurora Kinases|FLT3|Src|JAK|LRRK2|Hck|FGR|YES|Fyn|ARGSummary: Aurora A/B抑制剂